Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
The Office for Human Research Studies (OHRS) is the Dana-Farber Cancer Institute office that oversees the following committees and processes for the Dana-Farber/Harvard Cancer Center:
Scientific Review is a requirement of the NCI Cancer Center Support Grant (CCSG) that funds the DF/HCC. All cancer-relevant research at DF/HCC member institutions must be reviewed and approved by a SRC or through expedited administrative scientific review for prioritization, as permitted by the CCSG. The SRC assesses a research protocols scientific merit, prioritization and feasibility of trial completion, as well as the progress of approved research terminating research that no longer meets those criteria. OHRS manages five SRC panels.
The IRB is an administrative body established to protect the rights and welfare of human research subjects recruited to participate in research activities conducted under the auspices of the institution with which it is affiliated. The DFCI IRB functions as a single IRB of record for the clinical institutions that comprise the DF/HCC. OHRS manages seven IRB panels.
OHRS also manages Activation - the process where operational requirements to conduct the research are identified and verified as being complete before the research is permitted to begin. Operational requirements to conduct the research are identified and verified by OHRS as complete before the research is permitted to begin. Operational requirements are identified by institutional departments, including, but not limited to: Nursing, Pharmacy, Pathology, Clinical Trials Offices, DF/HCC Office for Data Quality (ODQ), DF/HCC Clinical Trials Research Informatics Office (CTRIO)
The Operations Manager for OHRS is primarily responsible for Intake and Online team operations in OHRS. The Intake team is responsible for verifying that incoming study team submissions meet minimum submission standards. The Online team is responsible for the final posting of IRB approved documents to OncPro. The operations manager further ensures the continued operation of the systems that support OHRS including Intake, Reviews and Online operations of OHRS. These include but are not limited to current systems (e.g. OnCore, OncPro, OHRS submit, P360, etc.) as well as future systems and enhancements under development.
Back end systems management includes managing the service queue for questions directed to OHRS. In addition, this individual is responsible for serving as the liaison with Information Systems (IS); the maintenance and development of databases that support the OHRS operations including the risk language database and the drug language database; as well as the OHRS website.
The Operations Manager also serves as the general office manager and is responsible for managing and overseeing all internal computers and equipment; production printers and scanners as well as ensuring the adequacy and capacity of equipment. The Operations Manager is responsible for staff time, purchasing and other general office matters. The Operations Manager must be able to provide direct support and training for the operations teams, including intake and online processing when understaffed or when a significant backlog occurs. The Operations Manager should gauge this need but also keep senior management informed of when his/her direct support is needed.
PRIMARY DUTIES AND RESPONSIBILITIES:
KNOWLEDGE, SKILLS, AND ABILITIES REQUIRED:
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.